Category
Oncology
155 medicines
Antineoplastic and supportive medicines frequently subject to allocation, regional shortages, or complex sourcing.
1-48 of 155 in this category
- AbemaciclibOncologyNot listed
- AbirateroneOncologyNot listed
- Abiraterone AcetateOncologyNot listed
- AcalabrutinibOncologyNot listed
- AfatinibOncologyNot listed
- Alectinib HydrochlorideOncologyNot listed
- AlpelisibOncologyNot listed
- AnastrozoleOncologyNot listed
- AvapritinibOncologyNot listed
- Avutometinib Potassium Defactinib HydrochlorideOncologyNot listed
- AxitinibOncologyNot listed
- AzacitidineOncologyInjectionIn shortage
- BaricitinibOncologyNot listed
- BendamustineOncologyTo be discontinued
- Bendamustine HclOncologyTo be discontinued
- Bendamustine HydrochlorideOncologyTo be discontinued
- BicalutamideOncologyNot listed
- Bictegravir Sodium Emtricitabine Tenofovir Alafenamide FumarateOncologyNot listed
- BinimetinibOncologyNot listed
- BleomycinOncologyNot listed
- Bleomycin SulfateOncologyNot listed
- BortezomibOncologyNot listed
- BosutinibOncologyNot listed
- BusulfanOncologyNot listed
- CabozantinibOncologyNot listed
- CapecitabineOncologyNot listed
- CapmatinibOncologyNot listed
- CarboplatinOncologyInfusionIn shortage
- CarmustineOncologyNot listed
- CeritinibOncologyNot listed
- ChlorambucilOncologyNot listed
- CisplatinOncologyInjectionNot listed
- ClofarabineOncologyNot listed
- CobimetinibOncologyNot listed
- CrizotinibOncologyNot listed
- CyclophosphamideOncologyNot listed
- CytarabineOncologyNot listed
- Cytarabine Liposome DaunorubicinOncologyNot listed
- DabrafenibOncologyNot listed
- DacarbazineOncologyNot listed
- DacomitinibOncologyTo be discontinued
- DactinomycinOncologyNot listed
- DasatinibOncologyNot listed
- Datopotamab DeruxtecanOncologyNot listed
- DaunorubicinOncologyNot listed
- Daunorubicin HydrochlorideOncologyNot listed
- DecitabineOncologyTo be discontinued
- DeucravacitinibOncologyNot listed
Supply column: FDA drug shortage database - checked 20 Sept 2026